Biologically aggressive breast cancers, particularly TNBC and poor prognosis luminal B breast cancers (ER+/HER2-wt or -amplified, Ki67 ≥14%) frequently exhibit high glucose consumption and aerobic glycolysis (195, 196). Here, ERBB2 is linked to breast cancer.